HEMOLYTIC ANEMIAS HA.

Slides:



Advertisements
Similar presentations
Normocytic Anemia David Lee, MD, FRCPC. Normocytic anemia a heterogenous group of anemias normocytosis implies normal DNA metabolism and hemoglobin synthesis.
Advertisements

HEREDITARY SPHEROCYTOSIS (HS). Introduction Hereditary spherocytosis is a class of hemolytic anemia. The disease occurs due to an intrinsic “membrane.
Anemia Dr. Meg-angela Christi M. Amores. What is Hematopoeisis? It is the process by which the formed elements of the blood are produced Erythropoeisis:
Case Study MICR Hematology Spring, 2011
Enzymopathies = ENZYME DEFECTS
Hemolytic Anemias due to Other Intracorpuscular Defects
 Charachterized by:  A nemia results when the rate of destruction exceeds the capacity of the m arrow to produce RBCs(The bone marro 8 times increased.
Course title: Hematology (1) Course code: MLHE-201 Supervisor: Prof. Dr Magda Sultan Outcome : The student will know : -The types of hemolytic anemias.
Week 2: Hemolytic Anemia
Pentose Phosphate Pathway Generation of NADPH and Pentoses.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY
MLAB 1415-Hematology Keri Brophy-Martinez
Laboratory diagnosis of Anemia
Glucose-6-phosphate Dehydration Deficiency Nada Mohamed Ahmed, MD, MT (ASCP)i.
Analysis of case study.
Course title: Hematology (1) Course code: MLHE-201 Supervisor: Prof
MLAB 1415: Hematology Keri Brophy-Martinez
Hemolytic Anemias Defined as those anemias result from an increased in the rate of red cell destruction. The red cell destruction is usually removed extravascular.
MLAB 1415-Hematology Keri Brophy-Martinez Chapter 14: Introduction to Hemolytic Anemias.
Glucose -6-phosphate dehydrogenase deficiency
Glucose-6-Phosphate Dehydrogenase
Faculty of Applied Medical Sciences Department Of Medical Lab. Technology 2 nd Year – Level 4 – AY Mr. Waggas Ela’as, M.Sc, MLT.
GLUCOSE-6-PHOSPATE DEHYDROGENASE DEFICIENCY GENETICS PRESENTATION BY GROUP A2(MD2) WINDSOR UNIVERSITY SCHOOL OF MEDICINE. IVEREN,FOLA,FLOURISH, ALLISON,
Haemolytic anaemias Dr. Suhair Abbas Ahmed.
Clinical Application for Child Health Nursing NUR 327 Lecture 3-D.
Glucose-6-Phosphate Dehydrogenase
Nada Mohamed Ahmed , MD, MT (ASCP)i
Acquired haemolytic anaemias
Hemolytic anemias.
MLAB 1415-Hematology Keri Brophy-Martinez Hemolytic Anemias: Enzyme Deficiencies.
HEMOLYTIC ANEMIAS.
Inherited and acquired haemolytic anaemias
CLASSIFICATION OF ANEMIA
MLAB 1415: Hematology Keri Brophy-Martinez
Red Cell Turnover and Life Span 2.5 million red cells are removed from the circulation every second. BM produces 200 billion new red cells (reticulocytes)
Glucose-6-Phosphate Dehydrogenase
Glucose-6-phosphate Dehydration Deficiency
Diagnostic Approaches To Anemia 1. Is the patient anemic ? 2. How severe is the anemia ? 3. What type of anemia ? 4. Why is the patient anemic? 5. What.
Approach to Anemia Sadie T. Velásquez, M.D.. Objectives.
Red cell membrane defects. Hereditary spherocytosis (HS) The most common of the inherited RBC membrane defects, affecting 1 in 5000 individuals. The disorder.
Hemolytic Anemia. Hemolysis is defined as the premature destruction of red blood cells (RBCs). Anemia results when the rate of destruction exceeds the.
Overviw Red cell enzyme Red cell enzyme Glucose-6-phosphate dehydrogenase deficiency Glucose-6-phosphate dehydrogenase deficiency Causes: Causes: Symptoms.
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives Intoduction Definition Classification Intravascular &extra vascular hemolysis Signs of hemolytic anemias.
Done by : Bara Shayib Supervised by : Dr. Abdullateef Alkhateeb.
MLAB Hematology Keri Brophy-Martinez
Department of Pathology. Iowa Anemia Cases Case Analyses by Dr. Schneider Tuesday, October 11, 2011 and Thursday October 13, 2011.
1 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE Chapter 20. Erythrocytic disorders.
MANGEMENT OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY
Hemolytic Anemia.
Hemolytic Anemias Definitions and Classification of Hemolytic Anemias
MLAB Hematology Keri Brophy-Martinez
Tabuk University Hematology – 1, MLT 205 Hereditary Spherocytosis
and BLEEDING DISORDERS
MLAB Hematology Keri Brophy-Martinez
Glucose-6-Phosphate Dehydrogenase Deficiency
Glucose-6-PhosphateDehydrogenase Deficiency Glucose-6-phosphate dehydrogenase (G6PD) deficiency, the most frequent disease involving enzymes of the.
MLAB 1415: Hematology Keri Brophy-Martinez
Anemia.
Megaloblastic anemias
Red cell membrane defects
Pentose Phosphate Pathway
HEMOLYTIC DISORDERS Red Cell Turnover and Life Span 2.5 million red cells are removed from the circulation every second. BM produces 200 billion new.
HEMOLYTIC ANEMIA Dr Ramadas Nayak
溶血性贫血 Hemolytic Anemia
Glucose-6-Phosphate Dehydrogenase
MLAB 1415-Hematology Keri Brophy-Martinez
Anemia case study Made by :Alaa duhair , Alaa alhoubi ,Shimaa Alshakhe. Under the supervision of : MS. Ibtisam Alaswad .
Approach to Haemolysis
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency
RED BLOOD CELLS (RBCs) Prof. Dr. Salwa Saad.
Presentation transcript:

HEMOLYTIC ANEMIAS HA

Hemolysis : an increased rate of RBC destruction with a shortening of the normal life span of the cell from the normal 120 days to as little as a few days in severe hemolysis. The marrow can increase erythrocyte production 6-8 fold so mild degrees of hemolysis are not associated with anemia. Severe hemolysis can lead to a rapid and profound fall in Hb, and be life threatening. It is suspected when polychromatic cells are seen on the blood film (reticulocytes). It is usually associated with raised blood unconjugated bilirubin and splenomegaly .

Hemolysis can be caused by inherited or acquired disorders. Diagnosis of the cause of the hemolysis is made according to the family history; clinical features and red cell morphology that together will indicate what further laboratory tests are required. Marrow examination is generally unnecessary.

The child with hemolysis may be pale with fluctuating jaundice (usually mild) and splenomegaly. Pigment gallstones may complicate the disorder ,HA should always be excluded in a child with stones. Aplastic crises may occur, usually precipitated by parvovirus infection which leads to reticulocytopenia and anemia. Parvovirus infection typically produces severe anemia sometimes requiring transfusion, and a modest thrombocytopenia and leucopenia.

Hemolytic anemia The major categories of HA are: 1-Immunemediated. 2-Membrane defect (Spherocytosis). 3-Enzyme defect(G6PD def). 4-Hb defect (SCA,Thalassemia).

Hereditary spherocytosis (HS) Membrane defects Hereditary spherocytosis (HS)

HS It is caused by a defect in the skeleton of the RBC membrane that generally affects the spectrin component. The characteristic finding is increased numbers of spherocytes in the peripheral blood. It is inherited as A.D in 75% of cases, other cases inheritant as A.R or new mutation.

Pathology In AD type the defect may be in either beta spectrin,ankyrin or protein 3. In AR form the defect is in either -protein or protein 4-2. This defect affect the RBC skeleton leading to budding of RBC memb, This bud is removed rapidly by the RES leading to loss of RBC surface area.The stretching ability of the RBC is very limited which lead to RBC rupture. The spherocyte have no easy transit through the splenic cord because of its shape this will affect glucose metabolism and decrease pH of RBC.

A, polychromatic cell; B, microspherocyte

Clinical pictures 1-May be asymptomatic with mild anemia & discovered accidentally. 2-The severe form may be started at early infancy with neonatal jaundice, severe anemia , splenomegaly & chronic blood transfusion. 3-Clinical pictures of complication, which are: A-Bone marrow aplasia after Parvo virus B19 infection. This v. infect erythroid cells in the BM & with arrest in development. The aplasia last for 10-14 days during which time the Hb drops by 50% with reticulocytopenia.

B-Hyper hemolysis after some viral infection lead to increasing anemia, reticulocytosis &jaundice. C-Delayed growth and sexual developments. D-Pigmented gallstones.

Laboratory diagnosis 1-CBC:A-anemia. B-high MCHC>36. C-high retic. count. D-normal MCH & MCV. E-spherocytes in peripheral blood. 2-Incubated osmotic fragility test is elevated. 3-High indirect bilirubin. 4-Decrease habtoglobin. 5-Membrane protein analysis for difficult cases

Management 1-In mild anemia with normal growth and development,we only observe the child and limit the intervention to folic acid tablet 1 mg/day. 2-Splenectomy for any child with chronic anemia or growth failure but we should defer it till the age of 5 yr to minimize the risk of sepsis & we should vaccinate the child by pneumococcal , H. influenza & menengiococcal vaccines at least 2 weeks before splenectomy & give the child prophylactic penicillin after splenectomy until at least 18 yr of age. In some reports,partial splenectomy appears to improve the anemia & maintain splenic function. 3-Elective cholecystectomy for symptomatic gallstones.

Glucose-6-phosphate dehydrogenase(G6PD) deficiency

G6PD deficiency is the most common RBC metabolic disorder G6PD deficiency is the most common RBC metabolic disorder. It is usually transmitted in an X-linked recessive fashion. Defects. The two prototypic forms are: The A- variant is found mainly in the black population and is associated with an isoenzyme that deteriorates rapidly (it has a half-life of 13 days). The Mediterranean variant is found mainly in individuals of Greek and Italian descent and is associated with almost complete absence of enzyme activity, even in young cells, due to extreme instability (it has a half-life of several hours).

Pathogenesis G6PD-deficient cells do not generate an amount of reduced glutathione that is sufficient to protect the RBCs from oxidant agents. Exposed sulfhydryl groups of Hb are oxidized, predisposing the molecule to denaturation. The heme and globin moieties dissociate, with the globin precipitating as Heinz bodies. The damaged RBCs are then removed by the RES; severely damaged cells may lyse intravascularly.

HA results from oxidative damage to the RBCs as consequence of the loss of the protective effect of the enzyme G6PD. The prevalence of G6PD def. is related to the prevalence of malaria as in Africa, it also high in mediterranean area.The incidence of P falceparum parasite is lower in G6PD def. patients.

The half life of the enz in normal RBC is 60 days,the mature RBC cannot synthesize the enz. The younger RBCs are relatively more resistant to hemolysis . The deficient RBC hemolysed when exposed to exogenous factors.The particles of the denaturated Hb,Heinz body,attach to the cell membrane causing irreversible damage and lysis, most of lysis occur intravascularly causing hemoglobinemia & hemoglobinuria. There may be an extravascular hemolysis which explain the splenomegaly in some cases.

Favism is the classical cause of acute hemolysis in G6PD def Favism is the classical cause of acute hemolysis in G6PD def. Fava bean contain the beta glycosides vicine & convicine These substances may undergo auto-oxidation as part of their metabolism, producing free O2 radicals. Acute hemolysis that occurs upon exposure to Fava is characterized by: 1-unpredictable(only 25%of adult at risk develop hemolysis). 2-Influence of dose and body weight. 3-Maturity of the bean. 4-Quality of bean(raw beans more than cooked, frozen or canned beans) 5-The activity of beta glucosidases in the bean & intestinal mucosa.

Drug induced hemolysis Many drugs and chemicals have been associated with hemolysis in G6PD def patient,These substances have the ability to stimulate the pentose phosphate PW in RBC which can lead to oxidation of NADPH . Infection-caused hemolysis During the process of phagocytosis of bacteria there is a release of peroxides by the phagocytosing granules, these peroxides lead to release of O radicals.

Clinical presentation There are three primary clinical presentation: 1-Neonatal jaundice. 2-Acute hemolysis beyond the neonatal period. 3-Chronic hemolysis (congenital non- spherocytic HA).

1-Neonatal jaundice: Acute hemolysis is characterized by onset of jaundice on the first few days of life that is out of the proportion to the degree of anemia. All infant with G6PD def develop NJ. NJ in G6PD def neonate may be an exaggerated physiological j or may be due to acute hemolysis caused by inciting agent like inf., drugs, naphthalene ball used in stored cloth diapers in developing country.

2-Acute hemolysis: Most pt with G6PD def. are asymptomatic until exposed to inciting agent at which time they may develop hemolysis.The onset of hemolysis is usually within 24-48 hr of exposure. The initial manifestation may include abdominal pain,vomiting or diarrhea,tea colored urine (hemoglobinuria),Jaundice, pallor with symptoms of anemia. Examination usually reveals: anemia , jaundice splenomegaly and hepatomegaly & in severe case symptom of heart failure.

Lab.finding in acute hemolysis include: 1-Normochromic normocytic anemia with anisopoikilocytosis, with few spherocyte . 2-Reticulocytosis. 3-Presence of bite cells (RBC bitten by macrophages). 4-Presence of hemigoast cells(RBC with uneven Hb distribution). 5-By using supravital stain we find inclusion bodies called Heinz body(denatured Hb). 6-Low serum haptoglobin. 7-High uncong. bilirubin. 8-Hemoglobinuria . 9- hemoglobinemia.

Diagnosis of G6PD def 1-Antenatal diagnosis can be made by performing G6PD assay on amniotic fl cells or from chorionic villi biopsy and DNA assay. 2-Screening test:semiquantitative test,this test should not be done during acute hemolysis because it lead to normal value.The usual cut of deficiency value is <30% of normal activity. 3-Quantitative assay: done several weeks after acute hemolysis when reticulocyte return to normal. 4-G6PD electrophoresis.

Differential diagnosis: 1-AIHA. 2-Malaria induced hemolysis. 3-Hepatitis Management of acute severe hemolysis 1-Removal of the inciting agent. 2-Brisk hydration to ensure adequate urine output. 3-blood transfusion. 4-Folic acid tablet 1mg/d for one month.

3-Chronic hemolysis Small minority of pt develop chronic H.Clinically all pts are male,presented with: 1-Neonatal j with anemia. 2-Jaundice and anemia. 3-splenomegaly. 4-Gallstone. 5-Acute hemolysis after exposure to oxidative agent. Lab. Finding: 1-CBC:anemia,reticulocytosis & polychromasia. 2-Low haptoglobin. 3-Hyberbilirubinemia.

Management 1-Folic acid administration. 2-Blood transfusion if indicated.

Drugs induce hemolysis in G6PD: ANALGESICS/ANTIPYRETICS acetophenetidin , amidopyrine ,aspirin ,phenacetin, probenicid . ANTIMALARIALS chloroquine, hydroxychloroquine mepacrine, pamaquine, pentaquine, primaquine, quinine, quinocide SULFONAMIDES/SULFONES dapsone, sulfacetamide, sulfamethoxypyrimidine, sulfanilamide ,sulfapyridine sulfasalazine ,sulfisoxazole . ANTIBACTERIAL chloramphenicol, cotrimoxazole, furazolidone, nalidixic acid, nitrofurantoin nitrofurazone , para-aminosalicylic acid. MISCELLANEOUS alpha-methyldopa, ascorbic acid dimercaprol (BAL), hydralazine , methylene blue ,nalidixic acid ,naphthalene, vitamin K (water soluble)